OXYGENTA PHARMACEUTICAL
|
The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 1.49.
| Share Price | ₹54.2 | Sep 04,2026 |
| Market Cap | ₹200.5 Cr | |
| Sales-TTM | ₹134.8 Cr | TTM-Standalone Results |
| Price/Sales | 1.49x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹200.5 Cr] as on Sep 04,2026
(/) Sales [ ₹134.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.49x ]
Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '1.49 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !
The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.
Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL
PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL
- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.79x.
- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 1.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2025 at 2.69x.
- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2022 of 0.56x.
How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| OXYGENTA PHARMACEUTICAL | 134.8 | 1.49 | 200.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.61 | 455,826.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.00 | 247,019.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.89 | 186,875.0 |
| CIPLA LTD | 28,324.4 | 3.98 | 112,773.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.88 | 95,570.9 |
| MANKIND PHARMA LTD | 14,737.9 | 6.51 | 95,911.1 |
| LUPIN LTD | 29,966.6 | 3.21 | 96,254.5 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.03 | 115,212.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.73 | 95,397.6 |
| LAURUS LABS LTD | 7,269.6 | 13.89 | 100,944.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.49x |
| Max industry PS | 22.00x |
| Median industry PS | 4.03x |
| Average industry PS | 7.29x |
You may also like the below Video Courses